This distributed approach prevents muscle loss while respecting the medication's natural appetite reduction
Pharmaceuticals, 18(2), 185.
The lawsuit states there is a risk and the companies knew about it from a 2024 study published in JAMA Ophthalmology which found a link between GLP1s and blindness yet decided not to list it as a rare side effect
Similar phenomena were found in the C@PA MN(+) and Se@PA MN groups
Urgent medical attention is warranted if you are already taking Ozempic and experience severe abdominal pain (which may indicate pancreatitis), persistent vomiting leading to dehydration (which can cause acute kidney injury), right upper quadrant pain with fever or jaundice (possible gallbladder disease), visual changes, signs of thyroid dysfunction, or symptoms of hypoglycaemia if taking other glucose-lowering medications
The one-month results patterns seen with semaglutide provide a useful comparison for what to expect with retatrutide, though the triple mechanism typically accelerates results once therapeutic doses are reached